Clinical Trial Update: Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) [Phase 2]

View source ↗

Summary

Phase 2 trial of Minnelide for advanced refractory adenosquamous carcinoma of the pancreas completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma of the Pancreas

Drugs mentioned

• Minnelide (minnelide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenosquamous Carcinoma of the Pancreas | Phase 2 | Status: COMPLETED | Results posted: 2025-10-07